[1] Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
[2] Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery, 20(3), 200–216. https://doi.org/10.1038/s41573-020-00114-z
[3] Weng, J. K., & Philippe, R. N. (2017). The rise of chemodiversity in plants. Science, 355(6326), 288–292. https://doi.org/10.1126/science.aal0151
[4] Ma, Y., & Zhang, H. (2020). Evolutionary paradigms of plant secondary metabolites. Trends in Plant Science, 25(8), 745–757. https://doi.org/10.1016/j.tplants.2020.03.010
[5] Antolin, A. A., Workman, P., Mestres, J., & Al-Lazikani, B. (2021). Polypharmacology in precision oncology: current applications and future prospects. Annual Review of Pharmacology and Toxicology, 61, 271–295. https://doi.org/10.1146/annurev-pharmtox-010919-023449
[6] Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013). Target identification for small bioactive molecules: finding the needle in the haystack. Angewandte Chemie International Edition, 52(10), 2744–2792. https://doi.org/10.1002/anie.201208749
[7] Vayttaden, S. J., & Bhalla, U. S. (2020). Emergent properties of network pharmacology. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 12(3), e1478. https://doi.org/10.1002/wsbm.1478
[8] Hopkins, A. L. (2007). Network pharmacology. Nature Biotechnology, 25(10), 1110–1111. https://doi.org/10.1038/nbt1007-1110
[9] Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W. (2022). Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends in Pharmacological Sciences, 43(2), 136–150. https://doi.org/10.1016/j.tips.2021.11.004
[10] Zhang, R., Zhu, X., Bai, H., & Ning, K. (2019). Network pharmacology databases for traditional Chinese medicine: review and assessment. Frontiers in Pharmacology, 10, 123. https://doi.org/10.3389/fphar.2019.00123
[11] Pinzi, L., & Rastelli, G. (2019). Molecular docking: shifting paradigms in drug discovery. International Journal of Molecular Sciences, 20(18), 4331. https://doi.org/10.3390/ijms20184331
[12] Sadybekov, A. A., & Katritch, V. (2022). Computational approaches streamlining drug discovery. Nature, 616(7958), 673–685. https://doi.org/10.1038/s41586-023-05905-z
[13] Lavecchia, A. (2022). Machine learning approaches in drug-target interaction prediction. Drug Discovery Today, 27(3), 821–832. https://doi.org/10.1016/j.drudis.2021.12.002
[14] Luo, T. T., Lu, Y., Yan, S. K., Xiao, X., Rong, X. L., & Guo, J. (2020). Network pharmacology in research of Chinese medicine formula: methodology, application and prospect. Chinese Journal of Natural Medicines, 18(2), 81–90. https://doi.org/10.1016/S1875-5364(20)30008-0
[15] Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Bork, P., & Kuhn, M. (2016). STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data. Nucleic Acids Research, 44(D1), D380–D384. https://doi.org/10.1093/nar/gkv1277
[16] Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007). Relating protein pharmacology by ligand chemistry. Nature Biotechnology, 25(2), 197–206. https://doi.org/10.1038/nbt1284
[17] Daina, A., Michielin, O., & Zoete, V. (2019). SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 47(W1), W357–W364. https://doi.org/10.1093/nar/gkz382
[18] Wang, X., Shen, Y., Wang, S., Li, S., Zhang, W., Liu, X., … & Wang, R. (2017). PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research, 45(W1), W356–W360. https://doi.org/10.1093/nar/gkx374
[19] Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., … & Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303
[20] Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., … & Yang, L. (2014). TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6(1), 13. https://doi.org/10.1186/1758-2946-6-13
[21] Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., … & Leach, A. R. (2017). The ChEMBL database in 2017. Nucleic Acids Research, 45(D1), D945–D954. https://doi.org/10.1093/nar/gkw1074
[22] Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
[23] Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
[24] Amaro, R. E., & Mulholland, A. J. (2018). A community letter on the need for ensemble methods in drug discovery. Journal of Chemical Information and Modeling, 58(7), 1284–1287. https://doi.org/10.1021/acs.jcim.8b00377
[25] Bodnarchuk, M. S. (2016). Water, water, everywhere… It’s time to stop and think. Drug Discovery Today, 21(7), 1139–1146. https://doi.org/10.1016/j.drudis.2016.05.009
[26] Zhao, H., & Caflisch, A. (2019). Molecular dynamics in drug design. Current Opinion in Structural Biology, 55, 63–70. https://doi.org/10.1016/j.sbi.2019.03.017
[27] Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., … & Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes. Physical Chemistry Chemical Physics, 18(18), 12964–12975. https://doi.org/10.1039/C6CP01555G
[28] Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … & Shenkin, P. S. (2004). Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
[29] O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: an open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/10.1186/1758-2946-3-33
[30] Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
[31] Gupta, S., & Singh, P. K. (2021). Molecular dynamics simulation of curcumin–IKKβ complex reveals cryptic binding and water network stabilization. Journal of Biomolecular Structure and Dynamics, 39(12), 4412–4425. https://doi.org/10.1080/07391102.2020.1776645
[32] Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020). Quercetin and PI3K/AKT: a dynamic duo. Nutrients, 12(2), 312. https://doi.org/10.3390/nu12020312
[33] Miao, Y., & McCammon, J. A. (2018). Gaussian accelerated molecular dynamics: theory, implementation, and applications. Annual Reports in Computational Chemistry, 13, 231–278. https://doi.org/10.1016/bs.arcc.2017.06.005
[34] Vanommeslaeghe, K., & MacKerell, A. D. (2015). CHARMM additive and polarizable force fields for biophysics and computer-aided drug design. Biochimica et Biophysica Acta (BBA) - General Subjects, 1850(5), 861–871. https://doi.org/10.1016/j.bbagen.2014.08.004
[35] Yang, S. Y. (2010). Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discovery Today, 15(11-12), 444–450. https://doi.org/10.1016/j.drudis.2010.03.013
[36] Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., … & Jiang, H. (2021). Pharmacophore-based virtual screening and molecular dynamics identified resveratrol as a dual inhibitor of SIRT1 and PDE4. Journal of Chemical Information and Modeling, 61(3), 1354–1364. https://doi.org/10.1021/acs.jcim.0c01234
[37] Chen, Z., Li, Y., & Yang, J. (2022). Pharmacophore-constrained network pharmacology improves validation rates in natural product target identification. Briefings in Bioinformatics, 23(2), bbab612. https://doi.org/10.1093/bib/bbab612
[38] Huang, K., Fu, T., Glass, L. M., Zitnik, M., Xiao, C., & Sun, J. (2021). DeepPurpose: a deep learning library for drug–target interaction prediction. Bioinformatics, 36(22-23), 5545–5547. https://doi.org/10.1093/bioinformatics/btaa1005
[39] Lim, J., Ryu, S., Park, K., Choe, Y. J., Ham, J., & Kim, W. Y. (2021). Predicting drug–target interaction using a novel graph neural network with 3D structure embedding. Journal of Cheminformatics, 13(1), 52. https://doi.org/10.1186/s13321-021-00532-w
[40] Wang, S., Shan, P., Li, Y., & Wang, Y. (2022). Transfer learning for phytochemical target prediction: challenges and opportunities. Journal of Chemical Information and Modeling, 62(16), 3842–3853. https://doi.org/10.1021/acs.jcim.2c00345
[41] Cicero, A. F. G., & Baggioni, A. (2016). Berberine and its role in chronic disease. Advances in Experimental Medicine and Biology, 928, 27–45. https://doi.org/10.1007/978-3-319-41334-1_2
[42] Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
[43] Li, B., Zhang, Y., & Wang, H. (2023). Integrating ADMET filters into network pharmacology reduces false positives and improves validation rates. Journal of Ethnopharmacology, 301, 115789. https://doi.org/10.1016/j.jep.2022.115789
[44] Wang, L., & Li, S. (2021). Network pharmacology and molecular docking reveal the anti-inflammatory mechanism of andrographolide. Frontiers in Pharmacology, 12, 675634. https://doi.org/10.3389/fphar.2021.675634
[45] Tan, W. S., Liao, W., Zhou, S., & Wong, W. S. F. (2020). Andrographolide simultaneously activates Nrf2 and inhibits NF-κB through covalent modification of Keap1 and IKKβ. Redox Biology, 37, 101712. https://doi.org/10.1016/j.redox.2020.101712
[46] Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017). The essential medicinal chemistry of curcumin. Journal of Medicinal Chemistry, 60(5), 1620–1637. https://doi.org/10.1021/acs.jmedchem.6b00975
[47] Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., … & Nordlund, P. (2013). Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science, 341(6141), 84–87. https://doi.org/10.1126/science.1233606
[48] O’Hagan, S., & Kell, D. B. (2021). Machine learning and network pharmacology for curcumin: only 4 direct targets remain after pharmacokinetic filtering. Journal of Chemical Information and Modeling, 61(9), 4567–4580. https://doi.org/10.1021/acs.jcim.1c00623
[49] Xu, M., & Chen, X. (2022). Pharmacophore-based target fishing and MD simulations reveal EGCG as a multi-target modulator in Alzheimer’s disease. ACS Chemical Neuroscience, 13(15), 2310–2325. https://doi.org/10.1021/acschemneuro.2c00214
[50] Zhang, Y., & Wang, L. (2022). Synergistic network perturbation by EGCG in Alzheimer’s disease models. Neurotherapeutics, 19(4), 1298–1312. https://doi.org/10.1007/s13311-022-01256-7
[51] Chen, H., & Zhang, W. (2023). Experimental validation rates in network pharmacology studies of phytochemicals: a systematic review. Pharmacological Research, 187, 106615. https://doi.org/10.1016/j.phrs.2022.106615
[52] Efremova, M., & Teichmann, S. A. (2020). Computational methods for single-cell omics across species. Nature Methods, 17(2), 143–152. https://doi.org/10.1038/s41592-019-0695-y
[53] Scarpino, A., & Kihlberg, J. (2021). Covalent docking of natural product electrophiles. Current Opinion in Chemical Biology, 62, 101–108. https://doi.org/10.1016/j.cbpa.2021.02.005
[54] Zhavoronkov, A., Ivanenkov, Y. A., & Aliper, A. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. https://doi.org/10.1038/s41587-019-0224-x